In adjusted models, seborrheic dermatitis was positively associated with a wide range of EBDs, including skin, respiratory, ...

Chromosome compartment analysis of a cancer cell line cohort reveals different subsets of compartment changes where some track epithelial to mesenchymal transition while others reflect secondary ...

A large U.S. study links seborrhoeic dermatitis to psoriasis, rosacea, and other barrier diseases, supporting the epithelial ...

Accession Therapeutics Limited, a biopharmaceutical company developing next generation cancer immunotherapies, today announced it has dosed the first patient in its Phase I clinical trial evaluating ...

In a significant stride for regenerative medicine, scientists have managed to reverse kidney damage in mice using innovative ...

Pneumonia affects your lungs significantly, and the air pollution can make the condition worse. Read on to know how air ...

Q3 2025 Earnings Call Transcript November 13, 2025 Operator: You all sites on hold. We appreciate your patience, and please ...

CytomX Therapeutics, Inc.'s ADC candidate, CX-2051, shows promise in colorectal cancer. Click here to read an analysis of ...

AnaptysBio plans to advance rosnilimab for RA, with a program update expected in the first half of 2026. Read why ANAB stock ...

A Swedish study of more than 2 million women found that breast cancer risk linked to hormonal contraception depends strongly ...

A protein previously linked to cancer and chronic illnesses has been found to have a natural health benefit. When doctors ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...